The aim of the present study was to evaluate the activity of the LHRH-agonist (Goserelin), in hormone-dependent breast cancer in dogs. The results showed that goserelin is effective in the treatment of hormone-dependent canine breast cancer, specifically acting on the hypothalamus-pituitary-ovary axis.
Goserelin is effective in the treatment of hormone-dependent canine mammary tumors / Lombardi, P., Avallone, L., Volpe, P., Tortora, G., D'Angelo, D., Scarfò, M., Florio, S.. - STAMPA. - 20(1):(1997), pp. 168-169. (7th European Association for Veterinary Pharmacology and Therapeutics Madrid (SPAIN) 6-10 july 1997).
Goserelin is effective in the treatment of hormone-dependent canine mammary tumors
LOMBARDI, PIETRO;AVALLONE, LUIGI;TORTORA, GENNARO;D'ANGELO, DANILA;FLORIO, SALVATORE
1997
Abstract
The aim of the present study was to evaluate the activity of the LHRH-agonist (Goserelin), in hormone-dependent breast cancer in dogs. The results showed that goserelin is effective in the treatment of hormone-dependent canine breast cancer, specifically acting on the hypothalamus-pituitary-ovary axis.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
